Intrinsic Therapeutics
ApprovedBarricaid helps herniated disc surgery patients by reducing the risk of reherniation and reoperation, offering a breakthrough solution for recovery.
Founded
2000
Focus
Medical DevicesOrthopedics
About
Barricaid helps herniated disc surgery patients by reducing the risk of reherniation and reoperation, offering a breakthrough solution for recovery.
Funding History
2Total raised: $65M
Series B$45MNew Enterprise AssociatesOct 15, 2021
Series A$20MUndisclosedMay 15, 2019
Company Info
TypePrivate
Founded2000
LocationWoburn, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile